

Avacta Demonstrates Initial Proof Of Concept For Cancer Drug TMAC


Affimer Unit Performance Helps Avacta Revenue Beat Market Forecasts


(Sharecast News) - Biotherapeutics development outfit Avacta doubled revenues in the 17-month period ended 31 December 2019 as it was boosted by an in...


Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director


(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has agreed to establish a joint venture in South Korea with Daewoong Pharmaceut...


Avacta To Establish Gene Therapy Joint Venture With Daewoong Pharma


Avacta Expands Contract With LG Chem After First Programme Completes


(Sharecast News) - Biotherapeutics developer Avacta Group updated the market on the 'Affimer' therapeutics development partnership and license agreeme...